Clinical Trials Browser

Phase 2 × Leukemia, Lymphocytic, Chronic, B-Cell × Sorafenib × Clear all

NCT01510756 2016-01-21

Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Phase 2 Terminated

4 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00303966 2014-05-07

Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Phase 2 Terminated

5 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell